Biotech firm to lay off St. Louis-area workers as it sells drug portfolio

The changes are because of the sale of seven hematology and oncology products, the company said.

Source: bizjournals.com Health Care:Biotechnology headlines - February 20, 2019 Category: Biotechnology Authors: Jacob Kirn Source Type: news